Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with all data for entry = 50016877
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM20877(CHEMBL183937 | JMC511145 Compound 2 | 3-(1-benzofu...)
Affinity DataIC50: 11nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174677((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 24nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174680((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 39nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174679((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 67nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM20877(CHEMBL183937 | JMC511145 Compound 2 | 3-(1-benzofu...)
Affinity DataIC50: 139nMAssay Description:Inhibitory activity towards human SGLT1 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174677((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 145nMAssay Description:Inhibitory activity towards human SGLT1 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174682((2S,3R,4S,5S,6R)-2-(3-(4-methoxyphenethyl)-1H-indo...)
Affinity DataIC50: 163nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174679((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 198nMAssay Description:Inhibitory activity towards human SGLT1 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174684((2S,3R,4S,5S,6R)-2-(3-(4-methoxyphenethyl)-3H-benz...)
Affinity DataIC50: 380nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174678((2S,3R,4S,5S,6R)-2-(3-(4-methoxyphenethyl)-6-methy...)
Affinity DataIC50: 394nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174681((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 458nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174675((2S,3R,4S,5S,6R)-2-(3-(2-(benzofuran-5-yl)ethyl)-6...)
Affinity DataIC50: 491nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174676((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 532nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174682((2S,3R,4S,5S,6R)-2-(3-(4-methoxyphenethyl)-1H-indo...)
Affinity DataIC50: 611nMAssay Description:Inhibitory activity towards human SGLT1 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174680((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 718nMAssay Description:Inhibitory activity towards human SGLT1 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174683((2S,3R,4S,5S,6R)-2-(3-(2-(2,3-dihydrobenzofuran-5-...)
Affinity DataIC50: 754nMAssay Description:Inhibitory activity towards human SGLT2 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetSodium/glucose cotransporter 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50174678((2S,3R,4S,5S,6R)-2-(3-(4-methoxyphenethyl)-6-methy...)
Affinity DataIC50: 3.05E+3nMAssay Description:Inhibitory activity towards human SGLT1 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed